A synthesis of classical and emerging evidence identifies mesenchymal stromal cell senescence as an intermediate amplifier of aging, converting molecular, metabolic, epigenetic, and inflammatory stress into altered chemokine output within the stem cell niche. This disrupted signaling repertoire undermines stem cell quiescence, activation, and differentiation, contributing to the progressive loss of tissue repair capacity. Senolytics, senomorphics, and stromal cell rejuvenation are proposed as routes to normalize niche-derived signals and preserve regenerative function.
Key Points
- Senescent stromal cells distort chemokine signaling that sustains stem cell function
- Niche dysfunction amplifies upstream stressors into chronic inflammation and repair decline
- Senolytics, senomorphics, and cell rejuvenation target restoration of signaling balance
Longevity Analysis
Regenerative decline is framed less as intrinsic stem cell exhaustion and more as a failure of the surrounding environment to issue correct instructions — a signaling problem before it is a cell-supply problem. Removing or silencing senescent stromal cells addresses the source of the interference rather than compensating downstream, which aligns with the broader principle that chronic inflammatory load and distorted intercellular communication constrain repair across tissues. For clinical translation, the measurable target becomes the secretory profile of the niche itself, linking immune surveillance, inflammatory tone, and the body's capacity to rebuild structural tissue over decades.
Original published by Wiley Aging Cell, by Shaianne N. Stein, Lorena R. Braid .